Functional ketchup?
This article was originally published in The Tan Sheet
Executive Summary
Heinz agreement to introduce DHA-, ARA-fortified infant formula in Australia, New Zealand gives Martek Biosciences an opportunity for future forays into functional foods market. H.J. Heinz subsidiary Heinz Wattie's Limited announces non-exclusive license agreement May 1 for use of Martek's DHA, ARA nutritional oil technology; the deal provides for initial cash payments and gives Martek an ongoing royalty once Heinz introduces fortified formula. Separately, Martek completes acquisition of OmegaTech April 25; DHA producer now is a wholly owned subsidiary of Martek and has become Martek Biosciences Boulder Corp. (1"The Tan Sheet" April 1, 2002, p. 3)...
You may also be interested in...
Martek Expands Access To DHA Food, Beverage Market With OmegaTech Buy
Martek Biosciences is looking to gain greater access to the nascent DHA-fortified food and beverage market with the acquisition of Boulder, Colo.-based OmegaTech
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.